Talazoparib Beneficial in Patients With Advanced Breast Cancer

Longer progression - free survival versus standard chemotherapy for patients with germline BRCA1/2
Source: The Doctors Lounge - Oncology - Category: Cancer & Oncology Tags: Gynecology, Oncology, Pharmacy, Journal, Source Type: news